Cingulate Inc. (CINGW) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-02-10

Key Insights

The reporting person, Matthew Brams, who is the EVP and Chief Medical Officer of Cingulate Inc. (CING), acquired 1,946 shares of common stock and 1,556 warrants in the company's private placement transaction.
The acquisition of shares and warrants by an executive officer suggests positive sentiment towards the company's future prospects.
The timing of the transaction, which occurred on February 6, 2026, is significant as it represents a recent investment by an insider in the company.

Want the newest filings?

This analysis covers the filing from 2026-02-10. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-02-10

Insider Shane J. Schaffer, who is the CEO and a director, purchased 6,809 shares of Cingulate Inc. (CING) at $5.04 per share in a private placement, indicating his confidence in the company.
The reporting person also holds warrants to purchase an additional 5,447 shares of Cingulate, further demonstrating his alignment with shareholders.
The private placement transaction was disclosed in a previous Form 8-K filing, providing transparency around the company's capital raising activities.

Filed: 2026-02-10

Jennifer L. Callahan, the SVP and CFO of Cingulate Inc., acquired 4,864 shares of the company's common stock at $5.04 per share, indicating her confidence in the company's prospects.
Callahan also acquired 3,891 warrants to purchase common stock at $5.04, exercisable upon the company obtaining stockholder approval for the private placement disclosed in the previous Form 8-K filing.
The insider buying activity suggests that the company's management is optimistic about the company's future performance and growth potential.

Filed: 2026-02-10

The reporting person, Peter J. Werth, acquired 19,455 shares of Cingulate Inc. (CING) common stock and 15,564 warrants to purchase common stock in a private placement transaction on February 6, 2026.
The reporting person's beneficial ownership has increased to 117,449 shares, including an indirect ownership of 117,449 shares and 15,564 warrants through Werth Family Investment Associates LLC.
The warrants are exercisable upon the issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules, and have an expiration date of 36 months after the exercise date.

Other reports for Cingulate Inc.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.